Stock Scorecard
Stock Summary for NovoCure Ltd (NVCR) - $18.54 as of 5/27/2025 2:13:24 PM EST
Total Score
9 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NVCR
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NVCR
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NVCR
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for NVCR
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for NVCR (34 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for NVCR
Financial Details for NVCR
Company Overview |
|
|---|---|
| Ticker | NVCR |
| Company Name | NovoCure Ltd |
| Country | USA |
| Description | NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is headquartered in Saint Helier, Jersey. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 6/5/2025 |
Stock Price History |
|
| Last Day Price | 18.54 |
| Price 4 Years Ago | 75.08 |
| Last Day Price Updated | 5/27/2025 2:13:24 PM EST |
| Last Day Volume | 869,910 |
| Average Daily Volume | 904,202 |
| 52-Week High | 34.13 |
| 52-Week Low | 14.17 |
| Last Price to 52 Week Low | 30.84% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 38.73 |
| Sector PE | 39.72 |
| 5-Year Average PE | -60.33 |
| Free Cash Flow Ratio | 16.26 |
| Industry Free Cash Flow Ratio | 36.41 |
| Sector Free Cash Flow Ratio | 31.24 |
| Current Ratio Most Recent Quarter | 1.47 |
| Total Cash Per Share | 1.14 |
| Book Value Per Share Most Recent Quarter | 3.25 |
| Price to Book Ratio | 5.71 |
| Industry Price to Book Ratio | 4.98 |
| Sector Price to Book Ratio | 29.89 |
| Price to Sales Ratio Twelve Trailing Months | 3.33 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.76 |
| Sector Price to Sales Ratio Twelve Trailing Months | 39.44 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 111,486,000 |
| Market Capitalization | 2,066,950,440 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -6.00% |
| Annual Earnings Growth | 18.55% |
| Reported EPS 12 Trailing Months | -1.51 |
| Reported EPS Past Year | -0.31 |
| Reported EPS Prior Year | -1.56 |
| Net Income Twelve Trailing Months | -164,186,000 |
| Net Income Past Year | -168,627,000 |
| Net Income Prior Year | -207,043,000 |
| Quarterly Revenue Growth YOY | 11.90% |
| 5-Year Revenue Growth | 11.49% |
| Operating Margin Twelve Trailing Months | -24.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 127,279,000 |
| Total Cash Past Year | 163,767,000 |
| Total Cash Prior Year | 240,821,000 |
| Net Cash Position Most Recent Quarter | 29,829,000 |
| Net Cash Position Past Year | 66,467,000 |
| Long Term Debt Past Year | 97,300,000 |
| Long Term Debt Prior Year | 568,822,000 |
| Total Debt Most Recent Quarter | 97,450,000 |
| Equity to Debt Ratio Past Year | 0.79 |
| Equity to Debt Ratio Most Recent Quarter | 0.79 |
| Total Stockholder Equity Past Year | 360,179,000 |
| Total Stockholder Equity Prior Year | 362,496,000 |
| Total Stockholder Equity Most Recent Quarter | 361,958,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -72,142,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.65 |
| Free Cash Flow Past Year | -69,224,000 |
| Free Cash Flow Prior Year | -100,429,000 |
Options |
|
| Put/Call Ratio | 0.03 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | -0.04 |
| 20-Day Bollinger Lower Band | 13.49 |
| 20-Day Bollinger Middle Band | 20.34 |
| 20-Day Bollinger Upper Band | 27.20 |
| Beta | 0.73 |
| RSI | 49.14 |
| 50-Day SMA | 20.22 |
| 150-Day SMA | 38.02 |
| 200-Day SMA | 52.25 |
System |
|
| Modified | 5/27/2025 6:25:44 AM EST |